A sensitive chemiluminescence method for measuring the production of superoxide anion (02-) by activated EoL-1 cells (human eosinophilic leukemia cell line) is described. Recently, we succeeded in synthesizing a new chemiluminescence probe, 8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4(2H,3H)dione (L-012). In the presence of L-012, activated EoL-1 cells which produce reactive oxygen species generated a marked chemiluminescence with negligible background. The L-012-dependent chemiluminescence was completely abolished by 100-300 U/ml superoxide dismutase, indicating that the main reactive oxygen species detected in this reaction was 02-. The light intensity and the sensitivity of L-012 to 02-were higher than those of other chemiluminescence probes such as luminol and Cypridina luciferin analog (MCLA). Thus, L-012 would provide an improved chemiluminescence method for measuring 02 from cells.
Many allergic disorders, including bronchial asthma and atopic dermatitis, are characterized by eosinophilia, and the infiltration of eosinophils to the bronchial or dermal tissue is a prominent feature in these disorders (1, 2) . These findings indicate that eosinophils play a crucial role as effector cells in allergic diseases (1) (2) (3) . When eosinophils as well as neutrophils interact with particulate or soluble stimuli, cells undergo respiratory burst accompanied by production of reactive oxygen metabolites.
Several investigators have reported that eosinophils displayed greater and more sustained 02-production than neutrophils in response to various stimuli (4) (5) (6) (7) , suggesting that 02 from eosinophils might be an important molecule in tissue damage in allergic diseases.
The classical techniques for measuring 02-, including ferricytochrome c reduction and nitroblue tetrazolium reduction, are of limited value by virtue of their integrative Abbreviations: L-012, 8-amino-5-chloro-7-phenylpyrido[3,4-c]pyridazine-1,4(2H, 3H)dione; 02-, superoxide anion; MCLA, 2-methy1-6-fp-methoxypheny11-3,7-dihydroimidazo[1,2-a]pyrazin-3-one; fMLP, N-formyl-methionyl-leucyl-phenylalanine; SOD, superoxide dismutase; PMA, phorbol 12-myristate-13-acectate; PAF, platelet activating factor. nature, their inability to detect intracellular events and their lack of sensitivity, requiring a relatively large number of cell concentrations (8) . As a consequence, the chemiluminescence method using luminol or 2-methy1-64p-methoxypheny11-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (MCLA) has been used for measurement of 02- (9, 10) . Herein, we describe a new chemiluminescence probe, 8-amino-5-chloro-7-phenylpyrido [3,4-d] pyridazine-1,4(2H,3H)dione (L-012) (11) that has higher sensitivity than luminol and MCLA.
MATERIALS AND METHODS

Materials
)dione (L-012) was synthesized according to a method described elsewhere (11) . Human recombinant complement C5a, N-formyl-methionyl-leucyl-phenylalanine (fMLP) and phorbol 12-myristate-13-acetate (PMA) were purchased from Sigma (St.Louis, MO, USA), luminol and MCLA from Tokyo Chemical Industry Co., LTD. Human eosinophilic leukemia cell line (EoL-1) was kindly provided by Dr. Hiroshi Saito (Sagamihara National Hospital, JAPAN). Human IFN-y and platelet activating factor (PAF) were prepared as described previously (12, 13) .
Cells
EoL-1 cells were maintained at 37°C in GIT medium (Wako Pure Chemical Industries LTD., Japan) supplemented with 5 % heat-inactivated fetal calf serum (culture medium). To differentiate the EoL-1 cells into mature eosinophilic cells, the cells were cultured for 3 days in the culture medium containing 100 U/mI IFN-y (IFN-y medium) at an initial concentration of 5 x 105 cells/ml. Then cells were readjusted to 5 x 105 cells/ml in the new IFN-y medium and cultured for another 3 days.
Chemiluminescence measurements IFN-y-treated EoL-1 cells were washed with the culture medium and were resuspended in this medium at 5 x 106 cells/ml. The cell suspension was kept in the dark at 4°C until use. Chemiluminescence was measured at 37°C with a Luminescence Reader (Aloka, BLR-201) as follows. Two hundred microliters of the cell suspension was placed in a glass vial and was preincubated at 37°C for 5 min. Then 5µl of various concentrations of the chemiluminescence probe was added to the cell suspension and the reaction mixture was incubated for another 2 min. The reactions were started by the addition of 5µl of a stimulatory agent such as C5a, fMLP, PAF and PMA. During luminescence measurement, the incubation mixture was rotatively agitated at 37°C in the Luminescence Reader. Chemiluminescence intensity was determined by measuring its peak height (counts per minutes: cpm) and by calculating the area under the chemiluminescence intensity curve (integral chemiluminescence). Chemiluminescence sensitivity was expressed as S/N, where S is the net chemiluminescence intensity and N the background luminescence.
RESULTS AND DISCUSSION
Among the luminol-derivatives synthesized (11), L-012 (8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4(2H,3H)dione) (Fig.1) was the most sensitive chemiluminescence probe to detect 02-(data not shown). In the present study we used the human eosinophilic leukemia cell line EoL-1 as the reactive oxygen producing cell, because it has been shown to differentiate into mature eosinophils by treatment with IFN- Addition of PAF or C5a instead of fMLP to IFN-y-treated EoL-1 cell suspension was also followed by rapid light production, similar to that obtained with fMLP stimulation (Fig.2-B,C) . In contrast, the light emission by PMA was gradually increased and reached a maximum intensity by 30 min (Fig.2-D) . In all cases, L-012-dependent chemiluminescence was suppressed by SOD in a dose-dependent manner and completely abolished by 100-300 U/ml of SOD (in case of fMLP stimulation, see in Fig.3 ),
indicating that the main reactive oxygen species detected in the reaction was 02-. • , control; 0 , 0.8 U/ml SOD; A , 4 U/ml SOD; A , 20 U/ml SOD; s , 100 U/ml SOD; u , 300 U/ml SOD.
Since luminol and MCLA have been the most commonly used chemiluminescence probes for monitoring 02-from phagocytic cells, L-012 was compared with these probes. The optimum concentrations of these chemiluminescence probes in our system were examined. The intensity of L-012-dependent chemiluminescence was increased in a dose-dependent manner and saturated at 500-800 µM of L-012. The highest sensitivity (S/N) was obtained at 500 µM of L-012 (Table 1 ). In the same way, the optimum concentration of luminol was examined and the highest sensitivity was obtained at 1250 µM. The intensity of MCLA-dependent chemiluminescence was increased in a dosedependent manner. However the background luminescence which was due to the selfquenching effect of MCLA (15) was also increased. Thus the optimum concentration of MCLA was regarded as 1 µM. Under each optimum concentration, the sensitivity (S/N) of L-012 was about 6-fold and 300-fold higher than those of luminol and MCLA, respectively ( Table 1 ).
The chemiluminescence generated from the IFN-y-treated EoL-1 cells following fMLP stimulation was compared under the optimum condition of each probe. The chemiluminescence intensity of L-012 was about 45-fold and 5-fold higher than those of luminol and MCLA, respectively (Fig. 4) . Similar results were obtained when PAF and C5a were used as stimulatory agents (data not shown). These findings indicate that L-012 is the most sensitive chemiluminescence probe for measuring 02-production from EoL-1 cells.
Eosinophils contribute to tissue injury in many allergic diseases (1, 2) . Several mechanism are involved in tissue injury induced by eosinophils. Recent attention has been focused on the injurious role of reactive oxygen metabolites in inflammatory diseases. Because reactive oxygen metabolites have been demonstrated to be deleterious to respiratory tissues, suppression of the 02-production could provide therapeutic benefit. Recently, some antiallergic drugs, such as azelastine, have been shown to inhibit the 02-generation from eosinophils and neutrophils (16, 17) . The sensitive L-012 chemiluminescence system described herein should be useful for developing the antiallergic drugs and for examining the biochemical mechanisms of respiratory burst.
